#$%^&*AU2010201136B220130124.pdf#####ABSTRACT The present invention provides a method of treatment of mammals to enhance immune 5 activity comprising administering a therapeutically effective amount of a composition comprising as the essential active ingredients a catalytic quantity of a selenium source together with a glutathione precursor which is a mixture of glutamic acid, cystine and glycine.